FDAFDA · Food and drugs·Recall number D-0048-2024
Doxil (doxorubicin hydrochloride liposome injection) 50 mg in 25 mL (2 mg/mL), Single-Dose Vial, Rx only, Manufactured for: Baxter Healthcare Corporation, Deerfield, IL 60015. NDC 0338-0067-01
Published October 25, 2023 · Recall initiated: August 24, 2023
Status when published: Terminated — openFDA updates weekly, so this field may not reflect the current status. Always confirm with the official notice.
What's the hazard
CGMP Deviations: Product was exposed to temperatures exceeding the labeled storage conditions during transportation were released by mistake.
What to do
Voluntary: Firm initiated · Letter
Recall details
- Brand
- DOXIL
- Manufacturer
- Baxter Healthcare Corporation
- Distributor
- Nationwide in the USA
- Lot
- Lot# MKZSU02, Exp 6/30/2024
- Risk classification
- Class II
- Area (FDA)
- drug
- Country
- United States
Sell products like this?
Recalert watches your whole catalog for recalls like this one, automatically.